Biofrontera AG: Correction notice regarding the H1 2025 report and the corresponding press release dated September 30, 2025, 00:18 a.m.

Leverkusen (pta051/30.09.2025/22:48 UTC+2)

"Reference document: Half-year financial report as of June 30, 2025 (German and English versions), published on September 30, 2025

Reason for correction:

Correction of contradictory information regarding the forecast due to typing errors

Affected text passages

Section "Outlook and Forecast" (German version): Table "Geänderte Prognose 2025" at the bottom of page 22 and the paragraph immediately below it

Section "Outlook and Forecast" (English version): Table "Revised forecast 2025" at the bottom of page 21 and the paragraph immediately below it

Corrected information (consistent with the forecast in the ad hoc announcement dated August 1, 2025)

EBITDA 2025: • Correct: EUR 1.5 to 3.5 million • Originally incorrectly stated: EUR 0.5 to 1.5 million

Cash and cash equivalents as of December 31, 2025: • Correct: EUR 1 to 3 million • Originally incorrectly stated: EUR 0.5 to 3 million

The corrected half-year financial report is available on the company's website.

The corresponding press release dated September 30, 2025, 00:18 a.m., which was equally incorrect, was corrected on September 30, 2025, 8:15 p.m.

The

Management Board"

(end)

Emitter:	Biofrontera AG Hemmelrather Weg 201 51377 Leverkusen Germany
Contact Person:	Investor Relations
Phone:	+49 (0) 214 87 63 20
E-Mail:	ir@biofrontera.com
Website:	www.biofrontera.com
ISIN(s):	DE000A4BGGM7 (Share)
Stock Exchange(s):	Regulated Market in Dusseldorf, Frankfurt; Free Market in Berlin, Munich, Stuttgart, Tradegate